Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils

American Journal of Neuroradiology

Volumn 23, Issue 9, 2002, Pages 1568-1576

  Workman, Michael J ^a   Cloft, Harry J ^a   Tong, Frank C ^a   Dion, Jacques E ^a   Jensen, Mary E ^a   Marx, William F ^a   Kallmes, David F ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BRAIN ARTERY ANEURYSM; CLINICAL ARTICLE; CLINICAL FEATURE; COIL EMBOLIZATION; DEVICE; DISEASE COURSE; EMBOLISM; FEMALE; HUMAN; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; THROMBOGENESIS; TREATMENT OUTCOME;

AGED; ANTIBODIES, MONOCLONAL; CEREBRAL ANGIOGRAPHY; EMBOLIZATION, THERAPEUTIC; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 0036796008     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Viñuela F, Duckwiler G, Mawad M. Guglielmi detachable coil embolization of acute intracranial aneurysm: perioperative anatomical and clinical outcome in 403 patients. J Neurosurg 1997;86:475-482
2. Cognard C, Weill A, Castaings L, Rey A, Moret J. Intracranial berry aneurysms: angiographic and clinical results after endovas-? cular treatment. Radiology 1998;206:499-510
3. Debrun GM, Aletich VA, Kehrli P, Misra M, Ausman JI, Charbel F. Selection of cerebral aneurysms for treatment using Guglielmi detachable coils: the preliminary University of Illinois at Chicago experience. Neurosurgery 1998;43:1281-1297
4. Guglielmi G, Vinũela F, Dion J, Duckwiler G. Electrothrombosis of saccular aneurysms via endovascular approach: part 2. preliminary clinical experience. J Neurosurg 1991;75:8-14
5. Lempert TE, Malek AM, Halbach VV, Phatouros CC, Dowd CF, Higashida RT. Rescue treatment of acute parent vessel thrombosis with glycoprotein IIb/IIIa inhibitor during GDC coil embolization. Stroke 1999;30:693-695
6. Cronqvist M, Pierot L, Boulin A, Cognard C, Castaings L, Moret J. Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: a comparison of anatomic results and clinical outcome. AJNR Am J Neuroradiol 1998;19:157-165
7. Tateshima S, Murayama Y, Gobin YP, Duckwiler GR, Guglielmi G, Viñuela F. Endovascular treatment of basilar tip aneurysms using Guglielmi detachable coils: anatomic and clinical outcomes in 73 patients from a single institution. Neurosurgery 2000;47:1332-1342
8. Pelz DM, Lownie SP, Fox AJ. Thromboembolic events associated with the treatment of cerebral aneurysms with Guglielmi detachable coils. AJNR Am J Neuroradiol 1998;19:1541-1547
9. White CJ, Ramee SR, Collins TJ, et al. Coronary thrombi increase PTCA risk: angioscopy as a clinical tool. Circulation 1996;93:253-258
10. Uretsky BF, Denys BG, Counihan PC, Ragosta M. Angioscopic evaluation of incompletely obstructing coronary intraluminal filling defects: comparison to angiography. Cathet Cardiovasc Diagn 1994;33:323-329
11. Guglielmi G, Vinũela F, Spetka I, Macellari V. Electrothrombosis of saccular aneurysms via endovascular approach: part 1. electrochemical basis, technique, and experimental results. J Neurosurg 1991;75:1-7
12. Horowitz M, Samson D, Purdy P. Does electrothrombosis occur immediately after embolization of an aneurysm with Guglielmi detachable coils? ANJR Am J Neuroradiol 1996;18:510-513
13. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696
14. Popma J, Prpic R, Lansky A, Piana R. Heparin dosing in patients undergoing coronary intervention. Am J Cardiol 1998;82:19P-24P
15. Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE. Heparin and low-molecular weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1998;114:489S-510S
16. Verheugt FW, Liem A, Zijlstra F, Marsh RC, Veen G, Bronzwaer JGF. High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study. J. Am Coll Cardiol 1998;31:289-293
17. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II Study: a randomized controlled trial. JAMA 1999;282:2003-2011
18. Lincoff A, Tcheng J, Califf R, et al. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) during percutaneous coronary revascularization. Am J Cardiol 1997;79:286-291
19. Boccara A, Benamer H, Juliard J, et al. A randomized trial of a fixed high dose vs a weight-adjusted low dose of intravenous heparin during coronary, angioplasty. Eur Heart J 1997;18:631-635
20. Hirsh J, Weitz JI. Thrombosis and anticoagulation. Semin Hematol 1999;36:118-132
21. Mabry CD, Thompson BW, Read RC, Campbell GS. Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of technique. Surgery 1981;90:889-895
22. Wallace RC, Furlan AJ, Moliterno DJ, Stevens GH, Masaryk TJ, Peri Perl J. Basilar artery rethrombosis: successful treatment with platelet glycoprotein IIB/IIIA. receptor inhibitor. AJNR Am J Neuroradiol 1997;18:1257-1260
23. Qureshi AI, Suri MF, Khan J, Fessler RD, Guterman LR, Hopkins LN. Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience. Neurosurgery 2000;46:1316-1325
24. The Abciximab in Ischemic Stroke Investigators. Abxicimab in acute ischemic stroke: a randomized, double-blind, placebo-controlled, dose-escalation study. Stroke 2000;31:601-609
25. Ng PP, Phatouros CC, Khangure MS. Use of glycoprotein IIb-IIIa inhibitor for a thromboembolic complication during Guglielmi detachable coil treatment of an acutely ruptured aneurysm. AJNR Am J Neuroradiol 2001;22:1761-1763
26. Gold HK, Garabedian HD, Dinsmore RE, et al. Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Circulation 1997;95:1755-1759
27. Reverter JC, Beguin S, Kessels H, Kumar R, Hemker HC, Coller BS. Inhibition of platelet- mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3. Antibody J Clin Invest 1996;98:863-874
28. Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999;99:3050-3055
29. Tsao P, Forsythe M, Mousa S. Dissociation between the anti-aggregatory and anti-secretory effects of platelet integrin alpha IIb beta 3 (GPIIb/IIIa) antagonists, c7E3 and DMP728. Thromb Res 1997;88:137-146
30. Shatos MA, Doherty JM, Garabedian HD, Gold HK. ReoPro, antiplatelet antibody, enhances fibrinolytic potential of cultured arterial microvascular cells. Circulation 1996;94:I-702